关注
Paul Lesueur, MD, PhD Student
Paul Lesueur, MD, PhD Student
Radiation Oncology Department, François-Baclesse Center
在 baclesse.unicancer.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
P Lesueur, F Chevalier, JB Austry, W Waissi, H Burckel, G Noel, ...
Oncotarget 8 (40), 69105, 2017
1232017
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
P Lesueur, J Lequesne, JM Grellard, A Dugué, E Coquan, PE Brachet, ...
BMC cancer 19, 1-11, 2019
1102019
Radiosensitization effect of talazoparib, a parp inhibitor, on glioblastoma stem cells exposed to low and high linear energy transfer radiation
P Lesueur, F Chevalier, EA El-Habr, MP Junier, H Chneiweiss, L Castera, ...
Scientific Reports 8 (1), 3664, 2018
872018
Hypoxia imaging and adaptive radiotherapy: a state-of-the-art approach in the management of glioma
M Gérard, A Corroyer-Dulmont, P Lesueur, S Collet, M Chérel, ...
Frontiers in medicine 6, 117, 2019
712019
Proton therapy for treatment of intracranial benign tumors in adults: A systematic review
P Lesueur, V Calugaru, C Nauraye, D Stefan, K Cao, E Emery, Y Reznik, ...
Cancer treatment reviews 72, 56-64, 2019
612019
Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
P Lesueur, J Lequesne, V Barraux, W Kao, J Geffrelot, JM Grellard, ...
Radiation Oncology 13, 1-10, 2018
432018
Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC
P Lesueur, A Escande, J Thariat, E Vauléon, I Monnet, A Cortot, ...
Cancer medicine 7 (11), 5505-5513, 2018
402018
Hadrontherapy interactions in molecular and cellular biology
J Thariat, S Valable, C Laurent, S Haghdoost, EA Pérès, M Bernaudin, ...
International journal of molecular sciences 21 (1), 133, 2019
242019
Adenoid cystic carcinoma of the lacrimal gland: high dose adjuvant proton therapy to improve patients outcomes
P Lesueur, E Rapeaud, L De Marzi, F Goudjil, C Levy, O Galatoire, ...
Frontiers in Oncology 10, 135, 2020
212020
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world …
M Sassier, AE Dugué, B Clarisse, P Lesueur, V Avrillon, ...
Lung Cancer 89 (2), 161-166, 2015
212015
Chondrosarcoma resistance to radiation therapy: Origins and potential therapeutic solutions
A Gilbert, M Tudor, J Montanari, K Commenchail, DI Savu, P Lesueur, ...
Cancers 15 (7), 1962, 2023
132023
High LET Radiation Overcomes In Vitro Resistance to X-Rays of Chondrosarcoma Cell Lines
F Chevalier, DH Hamdi, C Lepleux, M Temelie, A Nicol, JB Austry, ...
Technology in cancer research & treatment 18, 1533033819871309, 2019
132019
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
P Lesueur, G Damaj, K Hoang-Xuan, V Roland, A Schmitt, O Chinot, ...
Blood Advances 6 (16), 4807-4815, 2022
112022
Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review
P Lesueur, I Martel-Laffay, A Escande, M Kissel, C Locher, R Gervais, ...
Expert Review of Anticancer Therapy 18 (11), 1159-1165, 2018
102018
Apports de la protonthérapie à la radiothérapie d’aujourd’hui, pourquoi, comment?
J Thariat, JL Habrand, P Lesueur, A Chaikh, E Kammerer, D Lecomte, ...
Bulletin du Cancer 105 (3), 315-326, 2018
102018
Review of the mechanisms involved in the abscopal effect and future directions with a focus on thymic carcinoma
P Lesueur, F Chevalier, D Stefan, JL Habrand, D Lerouge, R Gervais
Tumori Journal 103 (3), 217-222, 2017
102017
Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions
DD Lecomte, J Lequesne, J Geffrelot, P Lesueur, V Barraux, C Loiseau, ...
Cancer/Radiothérapie 23 (8), 860-866, 2019
92019
Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies. Oncotarget. 2017; 8: 69105–24
P Lesueur, F Chevalier, JB Austry, W Waissi, H Burckel, G Noel
72019
Abscopal response in metastatic melanoma: real-world data of a retrospective, multicenter study
L Ollivier, C Orione, P Bore, L Misery, D Legoupil, JC Leclere, A Coste, ...
Cancers 14 (17), 4213, 2022
62022
Vemurafenib and concomitant stereotactic radiation for the treatment of melanoma with spinal metastases: a case report
D Stefan, H Popotte, AR Stefan, A Tesniere, A Tomaszewski, P Lesueur, ...
Reports of Practical Oncology and Radiotherapy 21 (1), 76-80, 2016
62016
系统目前无法执行此操作,请稍后再试。
文章 1–20